Your browser doesn't support javascript.
loading
Pharmacological modulation of b-adrenoceptors as a new cardioprotective strategy for therapy of myocardial dysfunction induced by ischemia and reperfusion
Menezes-Rodrigues, Francisco Sandro; Errante, Paolo Ruggero; Tavares, José Gustavo Padrão; Ferraz, Renato Ribeiro Nogueira; Gomes, Walter José; Taha, Murched Omar; Scorza, Carla Alessandra; Scorza, Fúlvio Alexandre; Caricati-Neto, Afonso.
Afiliação
  • Menezes-Rodrigues, Francisco Sandro; Universidade Federal de São Paulo. Department of Neurology and Neurosurgery. Postgraduate Program in Pharmacology. São Paulo. Brasil
  • Errante, Paolo Ruggero; Universidade Federal de São Paulo. Postgraduate Program in Pharmacology. São Paulo. Brasil
  • Tavares, José Gustavo Padrão; Universidade Federal de São Paulo. Postgraduate Program in Pharmacology. São Paulo. Brasil
  • Ferraz, Renato Ribeiro Nogueira; Universidade Nove de Julho. Postgraduate Program in Management of Health System. São Paulo. Brasil
  • Gomes, Walter José; Universidade Federal de São Paulo. Division of Cardiovascular Surgery. São Paulo. Brasil
  • Taha, Murched Omar; Universidade Federal de São Paulo. Department of Surgery. São Paulo. Brasil
  • Scorza, Carla Alessandra; Universidade Federal de São Paulo. Department of Neurology and Neurosurgery. São Paulo. Brasil
  • Scorza, Fúlvio Alexandre; Universidade Federal de São Paulo. Department of Neurology and Neurosurgery. São Paulo. Brasil
  • Caricati-Neto, Afonso; Universidade Federal de São Paulo. Department of Pharmacology. São Paulo. Brasil
Acta cir. bras. ; 34(5): e201900505, June 3, 2019. graf
Article em En | VETINDEX | ID: vti-23226
Biblioteca responsável: BR68.1
Localização: BR68.1
ABSTRACT

Purpose:

To evaluate the cardioprotective response of the pharmacological modulation of β-adrenergic receptors (β-AR) in animal model of cardiac ischemia and reperfusion (CIR), in spontaneously hypertensive (SHR) and normotensive (NWR) rats.

Methods:

CIR was induced by the occlusion of left anterior descendent coronary artery (10 min) and reperfusion (75 min). The SHR was treated with β-AR antagonist atenolol (AT, 10 mg/kg, IV) 5 min before CIR, and NWR were treated with β-AR agonist isoproterenol (ISO, 0.5 mg/kg, IV) 5 min before CIR.

Results:

The treatment with AT increased the incidence of VA, AVB and LET in SHR, suggesting that spontaneous cardioprotection in hypertensive animals was abolished by blockade of β-AR. In contrast, the treatment with ISO significantly reduced the incidence of ventricular arrhythmia, atrioventricular blockade and lethality in NWR (30%, 20% and 20%, respectively), suggesting that the activation of β-AR stimulate cardioprotection in normotensive animals. Serum CK-MB were higher in SHR/CIR and NWR/CIR compared to respective SHAM group (not altered by treatment with AT or ISO).

Conclusion:

The pharmacological modulation of β-AR could be a new cardioprotective strategy for the therapy of myocardial dysfunctions induced by CIR related to cardiac surgery and cardiovascular diseases.(AU)
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: VETINDEX Assunto principal: Doenças Cardiovasculares / Receptores Adrenérgicos beta Limite: Animals Idioma: En Revista: Acta cir. bras. Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: VETINDEX Assunto principal: Doenças Cardiovasculares / Receptores Adrenérgicos beta Limite: Animals Idioma: En Revista: Acta cir. bras. Ano de publicação: 2019 Tipo de documento: Article